Clinical and Radiological Outcomes of One-Stage Surgery for Developmental Dislocation of the Hip in Children

Liu Zhu,Li Hao,Zhang Zhiqiang,Chen Qiu,Li Hai,Fan Qing,Zhang Ziming
DOI: https://doi.org/10.3760/cma.j.issn.0253-3006.2017.07.006
2017-01-01
Abstract:Objective To evaluate the clinical and radiological outcomes of one-stage surgery for developmental dislocation of the hip (DDH) in children and explore whether such a procedure increase the risk of avascular necrosis (AVN) in children aged 2 to 3 years.Methods From January 2009 to December 2010,a total of 31 children (45 hips) aged 2 to 6 years received one-stage surgeries including open reduction,Salter innominate osteotomy and proximal femoral osteotomy They were divided into two groups according to treatment age:Group 1 (28 hips) aged ≤3 years and Group 2 (17 hips) aged 3-6 years.T(o)nnis and Kalamchi-MacEwen classifications were used for classifying the radiographic features of hip at pre and post-operation.Thirty hips were defined as grade Ⅲ (21 hips in group 1;9 hips in group 2) and 15 hips grade Ⅳ (7 hips in group 1;8 hips in group 2).Clinical outcomes were assessed with the modified McKay's scoring system.Results The mean operative age was 37.22 ± 11.60 months and the mean follow-up period 5.93 ± 0.76 years.According to the Kalamchi-MacEwen classification,AVN was observed in 14 hips (31.1%) at the final follow-up.In group 1,AVN was present in 9 hips (32.1 %).The grades were Ⅰ (44.4 %),Ⅱ (11.1 %),Ⅲ (33.3%) and Ⅳ (11.1%).In group 2,AVN was found in 5 hips (29.4 %).And the grades were defined Ⅰ (60%),Ⅱ (20%) and Ⅳ (20%).No significant inter-group difference existed (P =0.560).Furthermore,according to McKay's scoring system,73.3% patients yielded excellent outcomes whereas 15.6% had good results.No significant inter-group difference was noted (P =0.944).One patient required re-operation for residual subluxation.And the re-operative rate was 2.22%.Conclusions One-stage procedures of open reduction,Salter innominate osteotomy and proximal femoral osteotomy are efficacious for DDH in children aged 2-6 years.Also it is safe for patients aged ≤3 years to obtain satisfactory clinical outcomes without a higher risk of AVN.
What problem does this paper attempt to address?